Nectin Therapeutics

About:

Nectin Therapeutics is a startup company dedicated to the development of next generation immuno-oncology antibodies.

Website: http://www.nectintx.com/

Top Investors: EIC Accelerator, Integra Holdings, Cancer Focus Fund, aMoon Fund, Peregrine Ventures

Description:

Nectin Therapeutics is developing novel monoclonal antibodies directed towards members of the Nectin family of receptors and ligands that have major roles in the immune checkpoint mechanisms relevant for cancer immune therapy. These novel antibodies are developed for the treatment of solid and hematological malignancies.

Total Funding Amount:

$46.4M

Headquarters Location:

Jerusalem, Yerushalayim, Israel

Founded Date:

2017-01-01

Contact Email:

info(AT)nectintx.com

Founders:

Ofer Mandelboim, Pini Tsukerman

Number of Employees:

11-50

Last Funding Date:

2024-05-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai